Saturday, January 1 2022

My battery's about to run out ivermectin 6 mg prospecto Regeneron and Sanofi are among a handful of companies, including Amgen Inc. (AMGN) and Pfizer Inc. (PFE), developing new cholesterol-fighting treatments that suppress a protein called PCSK9 that makes it difficult for the body to clear LDL--low-density lipoprotein, known as bad cholesterol--from the blood. The drugs could be used in addition to statins by patients with stubbornly high LDL levels and in patients such as those in the Regeneron study who can't tolerate statins.

My battery's about to run out ivermectin 6 mg prospecto Regeneron and Sanofi are among a handful of companies, including Amgen Inc. (AMGN) and Pfizer Inc. (PFE), developing new cholesterol-fighting treatments that suppress a protein called PCSK9 that makes it difficult for the body to clear LDL--low-density lipoprotein, known as bad cholesterol--from the blood. The drugs could be used in addition to statins by patients with stubbornly high LDL levels and in patients such as those in the Regeneron study who can't tolerate statins.


Download as iCalendar

Done